메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

'김갑성' 기자의 전체기사

Belief BioMed Congratulates Partner AskBio on IND Acceptanc…

SHANGHAI, Jan. 15, 2026 -- AskBio Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, recently announced that the United States Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application for AB-1009, an investigational adeno-associated virus (AAV) gene therapy being developed for the treatment of late-onset Pompe disease. With this announcement, the AB-1009 program advances to Phase 1/2, and AskBio initiates a clinical trial in the United States to explore the safety of AB-1009. The company anticipates
- 김갑성 기자
- 2026-01-15 12:11
JPM Highlights | WuXi Biologics CEO Dr. Chris Chen: Scaled CRDM…

[ 메디채널 김갑성 기자 ] Total of 945 integrated projects in 2025, including 74 Phase III clinical projects and 25 commercial manufacturing projects 209 new integrated projects in 2025 set a new record, with approximately 50% originating from U.S. clients Complex modalities are WuXi Biologics' core growth engine, with 2/3 of the new integrated projects comprising bispecific/multispecific antibodies and ADCs Bispecific/multispecific antibodies are WuXi Biologics' most exciting, fastest‑growing and highest‑margin engine. With 196 projects in the pipeline, this modality contributes nearly 20% of t
- 김갑성 기자
- 2026-01-15 12:00
Hyundai Bioscience Confirms Entry into U.S. FDA Phase 2 Trials…

- UCSD's Dr. Davey Smith, former ACTIV-2 Protocol Chair, endorses 'Xafty' as "The weapon to end the virus war." - Announces "One Drug, Two Tracks" strategy: Targeting Dengue in Vietnam and Respiratory Viruses (Flu, COVID, RSV) in the U.S. with the same drug. - Dr. Davey Smith: "With this multi-virus treatment, 2026 may mark the inaugural year of modern treatments that can treat multiple viruses with one drug, perhaps even viruses that haven't hit us yet." SAN FRANCISCO, Jan. 15, 2026 -- Hyundai Bioscience (KOSDAQ: 048410) today announced a groundbr
- 김갑성 기자
- 2026-01-15 11:34
International Healthcare Week Returns to Thailand in 2026 with…

BANGKOK, Jan. 15, 2026 -- International Healthcare Week is set to return to Thailand (8-10 July 2026, Queen Sirikit National Convention Center, Bangkok), bringing together the region's most influential health and wellness stakeholders. Organised by Informa Markets, this flagship event will co-locate three major exhibitions: CPHI South East Asia, WHX Bangkok (formerly Medlab Asia and Asia Health), and Medtec Southeast Asia. These events will unite cutting-edge pharmaceutical, medical device, medical laboratory and design and manufacturers of medical devices under one roof, attracting an expect
- 김갑성 기자
- 2026-01-15 10:42
HNC Expo 2025 Concluded Successfully in Shenzhen, Next Sto…

SHENZHEN, China, Jan. 15, 2026 -- During December 16-18, 2025, the "Healthplex Expo, Natural & Nutraceutical Products Shenzhen" (HNC Shenzhen), co-organized by CCCMHPIE and Sinoexpo Informa Markets, was held successfully at the Shenzhen World Exhibition & Convention Center. With Shenzhen as its anchor city, the exhibition fully leveraged the Greater Bay Area's industrial concentration to create a professional platform integrating brand showcase, trend launches, technical exchange and business matchmaking. It drew strong participation from companies across the global health a
- 김갑성 기자
- 2026-01-15 10:00
AIM's Iterative Process High-Efficiency Diploid Rabies Vaccine…

HONG KONG, Jan. 15, 2026 -- AIM Vaccine (06660.HK), a leading domestic vaccine company, announced on January 15 that its research and development of the iterative process high-efficiency diploid rabies vaccine has successfully completed the Phase III clinical site work. This marks the official entry of the vaccine into a new phase, laying a solid foundation for future commercialization. At this critical juncture where the vaccine industry is shifting from "scale expansion" to "value competition," AIM's iterative rabies vaccine will provide strong support for the company's
- 김갑성 기자
- 2026-01-15 08:30
Heartstream Launched as Independent Emergency Care C…

Former Philips Emergency Care business becomes first platform company of Emergency Care Holdings, advancing a century-long mission to save lives BOTHELL, Wash., Jan. 15, 2026 -- Emergency Care Holdings (ECH), a platform formed by Bridgefield Capital to assemble and grow category-leading companies in the emergency medical products sectors, announced the debut of Heartstream today, a new independent company dedicated to advancing life-saving emergency care technologies. Heartstream is formed through ECH's completed acquisition of the Philips Emergency Care business from Ro
- 김갑성 기자
- 2026-01-15 00:45
Metabolon Appoints Celia Reyes as Vice President of Human…

Celia Reyes will lead Metabolon's global people strategy as the company continues to scale in the evolving multiomics marketplace MORRISVILLE, N.C., Jan. 14, 2026 -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications, announces the appointment of Celia Reyes as Vice President of Human Resources. "We are delighted to welcome Celia to the Metabolon leadership team," said Rohan Hastie, Ph.D., President and CEO of Metabolon
- 김갑성 기자
- 2026-01-14 22:00
Yuyu Pharma Establishes UCLA Office to Accelerate U.S. Pet Ind…

SEOUL, South Korea, Jan. 14, 2026 -- Yuyu Bio and Mervyn's Petcare, pet-focused subsidiaries of Yuyu Pharma, have opened a new office on the UCLA campus, strengthening the company's presence in the United States pet and animal health market. The two companies are now based at Magnify, the startup incubator housed within the California NanoSystems Institute (CNSI) at UCLA. Magnify provides office space, meeting facilities, and access to a dynamic innovation ecosystem. The new office will serve as Yuyu Pharma's North American base for pet-related ventures, enabling
- 김갑성 기자
- 2026-01-14 22:00
NYSE Content Advisory: Pre-Market Update + Inaugural U.S.-Sau…

NEW YORK, Jan. 14, 2026 -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. NYSE Content Advisory: Pre-Market Update + Inaugural U.S.-Saudi Biotech Alliance Summit Begins in SF Kristen Scholer delivers the pre-market update on January 14th U.S. equities traded fractionally lower pre-market as investors digest a packed agenda, including earnings from major banks, speeches from several Fed officials, key economic data,
- 김갑성 기자
- 2026-01-14 21:55

이전

11 12 13 14 15 16 17 18 19 20

많이 본 기사

최근기사

2026-01-31_SAT

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2026년 01월 31일 13시 40분